|
|
Sean Tunis, Center for Medical Technology Policy
Susan Molchan, Alzheimer’s Disease Neuroimaging Initiative, National Institute on Aging (NIH)
|
|
|
Question & Answer/Open Discussion
|
|
10:15
|
Break
|
|
10:30
|
Panel 2—Avastin and Lucentis for Age Related Macular Degeneration. Moderator: Diana Petitti (Kaiser Permanente, Southern California)
|
|
|
Reginald Sanders, American Society of Retina Specialists
Winifred Hayes, Hayes, Inc.
Steve Phurrough, CMS Coverage and Analysis Group
Dan Martin, Emory University School of Medicine
|
|
|
Question & Answer/Open Discussion
|
|
12:15
|
Lunch
|
|
1:00
|
Panel 3—Screening and Treating Colorectal Cancer—The Fecal DNA Test and an Assay for Irinotecan Toxicity. Moderator: Steve Shak (Genomic Health, Inc.)
|
|
|
Barry Berger, Exact Sciences Corporation
Margaret Piper, Blue Cross and Blue Shield Association Technology Evaluation Center
Richard Goldberg, University of North Carolina, Chapel Hill
Atiqur Rahman, Food and Drug Administration, Center for Drug Evaluation and Research
|
|
|
Question & Answer/Open Discussion
|
|
3:00
|
Break
|
|
3:15
|
Panel 4—Experts React. Moderator: Hal Sox, Vice Chair, IOM Committee
|
|
|
Daniel Cain, Cain Brothers
Peter Juhn, Health Policy and Evidence, Johnson & Johnson
Cindy Mulrow, University of Texas and the American College of Physicians
David Ransohoff, University of North Carolina Chapel Hill, School of Medicine
Earl Steinberg, Resolution Health
|
